We are live on ! Find out more
Axa

Axa Portfolio holdings

AUM $91.9M
1-Year Est. Return 27.41%
This Fund
S&P 500
This Quarter Est. Return
+7.97%
1 Year Est. Return
+27.41%
3 Year Est. Return
+100.68%
5 Year Est. Return
+129.89%
10 Year Est. Return
+554.73%
AUM
$27.3B
AUM Growth
+$1.17B
Cap. Flow
-$1B
Cap. Flow %
-3.68%
Top 10 Hldgs %
13.33%
Holding
1,440
New
99
Increased
518
Reduced
438
Closed
115

Top Buys

Rank Stock Value
1
INTC icon
Intel
INTC
+$58.6M
2
CHTR icon
Charter Communications
CHTR
+$45.8M
3
CACC icon
Credit Acceptance
CACC
+$44.9M
4
HD icon
Home Depot
HD
+$43M
5
ADSK icon
Autodesk
ADSK
+$40.5M

Top Sells

Rank Stock Value
1
DXCM icon
DexCom
DXCM
+$77.5M
2
AAPL icon
Apple
AAPL
+$73.3M
3
META icon
Meta Platforms (Facebook)
META
+$64.7M
4
MRK icon
Merck
MRK
+$58.9M
5
QCOM icon
Qualcomm
QCOM
+$56.8M

Sector Composition

Rank Sector Weight
1 Technology 23.03%
2 Healthcare 16.1%
3 Financials 11.41%
4 Consumer Discretionary 10.23%
5 Industrials 9.2%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CPAY icon
1376
Corpay
CPAY
$26.8B
-20,101
Closed -$4.23M
VRN
1377
DELISTED
Veren
VRN
-12,309
Closed -$90K
AAMI
1378
Acadian Asset Management
AAMI
$3.23B
-22,300
Closed -$318K
QVCGA
1379
DELISTED
QVC Group Inc Series A
QVCGA
-3,367
Closed -$3.47M
CUTR
1380
DELISTED
Cutera, Inc.
CUTR
-5,600
Closed -$226K
CDMO
1381
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
-48,900
Closed -$192K
SMMF
1382
DELISTED
Summit Financial Group, Inc.
SMMF
-9,465
Closed -$254K
IMGN
1383
DELISTED
Immunogen Inc
IMGN
-20,007
Closed -$195K
ACOR
1384
DELISTED
Acorda Therapeutics
ACOR
-70
Closed -$241K
SEAC
1385
DELISTED
Seachange International Inc
SEAC
-8,265
Closed -$565K
HIL
1386
DELISTED
Hill International, Inc. Common Stock
HIL
-10,100
Closed -$60K
GBT
1387
DELISTED
Global Blood Therapeutics, Inc.
GBT
-5,100
Closed -$231K
CDK
1388
DELISTED
CDK Global, Inc.
CDK
-11,386
Closed -$741K
XENT
1389
DELISTED
Intersect ENT, Inc
XENT
-18,176
Closed -$681K
XEC
1390
DELISTED
CIMAREX ENERGY CO
XEC
-49,741
Closed -$5.06M
PFBI
1391
DELISTED
Premier Financial Bancorp
PFBI
-17,543
Closed -$328K
OXFD
1392
DELISTED
Oxford Immunotec Global PLC Ordinary Shares
OXFD
-479,975
Closed -$6.19M
ARA
1393
DELISTED
American Renal Associates Holdings, Inc
ARA
-12,000
Closed -$189K
BFYT
1394
DELISTED
Benefytt Technologies, Inc. Class A Common Stock
BFYT
-19,800
Closed -$641K
LM
1395
DELISTED
Legg Mason, Inc.
LM
-49,300
Closed -$1.71M
AVX
1396
DELISTED
AVX Corporation
AVX
-14,000
Closed -$219K
MCRN
1397
DELISTED
Milacron Holdings Corp.
MCRN
-23,600
Closed -$447K
ALDR
1398
DELISTED
Alder Biopharmaceuticals
ALDR
-19,700
Closed -$311K
NCI
1399
DELISTED
Navigant Consulting, Inc.
NCI
-19,200
Closed -$425K
UPL
1400
DELISTED
Ultra Petroleum Corp. Common Stock
UPL
-30,300
Closed -$70K

Similar funds

Axa's Q3 2018 Portfolio in Review

As of Q3 2018, Axa held 1,440 positions worth $27.3B, up 4.5% from $26.1B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

Axa withdrew a net $1B in Q3 2018, closing 115 positions and reducing 438 holdings. Its most notable exit was CA, Inc., an estimated $56.1M position sold in full.

By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 23% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Axa opened a new position in KKR & Co worth $27.3M.

  • Axa's largest Q3 2018 buy was KKR & Co: 1,000,000 shares worth $27.3M.
  • Axa added most to Intel in Q3 2018, an estimated $58.6M increase.
  • Axa's biggest Q3 2018 reduction was DexCom, cutting an estimated $77.5M.
  • Axa fully exited CA, Inc. in Q3 2018, selling an estimated $56.1M.
  • Axa's ten largest holdings make up 13% of its $27.3B portfolio in Q3 2018.
  • Axa opened 99 new positions and closed 115 in Q3 2018.
  • Axa's portfolio value rose 4.5% quarter-over-quarter to $27.3B.

Based on Axa's 13F filing for Q3 2018, filed 8 Nov 2018.